Growth Hormone Deficiency
📧 Sign up to get email alerts when something new happens for Growth Hormone Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD) [Phase 2]
Phase 2 clinical trial update for GS3-007a in adults with growth hormone deficiency; the study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Development of a Personalized Growth Hormone Treatment Profile (PGTP) Report for Pediatric Endocrinology
A completed clinical trial update on developing a personalized growth hormone treatment profile (PGTP) report for pediatric growth hormone d…
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: Skeletal Muscle Effects of GH in Boys
A completed clinical trial evaluating the effects of growth hormone on skeletal muscle in boys with growth hormone deficiency or idiopathic …
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Ngenla Subcutaneous Injection Special Investigation
Pfizer reports an ongoing clinical trial evaluating Ngenla (somatrogon) for growth hormone deficiency without epiphyseal closure. The study …
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Evolution of the Quality of Life of Short Statured Children Treated With Growth Hormone : Evaluation at Adult Size
This completed clinical trial from Assistance Publique - Hôpitaux de Paris evaluates the evolution of quality of life at adult size in child…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg
This entry describes an ongoing clinical trial (NCT06037473) assessing the efficacy and safety of a PEGylated growth hormone for treating sh…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy
This completed clinical trial from Istituto Auxologico Italiano investigates biological age in children with growth hormone deficiency who a…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: The AgRP and GH/IGF-1 Axis in Children
A Columbia University-sponsored clinical trial is investigating the role of the AgRP and GH/IG-1 axis in children with Growth hormone defici…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study of GB08 injection for pediatric growth hormone deficiency, which is currently n…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency [Phase 3]
Phase 3 long-term safety extension study of LUM-201 in children with growth hormone deficiency; the trial is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT) [Phase 2]
Phase 2 clinical trial evaluating growth hormone replacement in veterans with Gulf War syndrome and adult growth hormone deficiency; current…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: A Bioequivalence Study of Two Different PEG-rhGH Preparations [Phase 1]
Phase 1 bioequivalence study comparing two PEG-rhGH preparations completed in pediatric growth hormone deficiency.
-
FDA approval · 2025-07-25FDA Approved: SKYTROFA — Supplemental Application (Ascendis Pharma Endocrinology, Inc.)
FDA approved a supplemental application for SKYTROFA (lonapegsomatropin-tcgD) from Ascendis Pharma Endocrinology, Inc.
-
FDA approval · 2025-07-09FDA Approved: NGENLA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for NGENLA (somatrogon-GHLA) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2025-07-09FDA Approved: OMNITROPE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for OMNITROPE (somatropin) submitted by Sandoz Inc.
-
FDA approval · 2025-07-09FDA Approved: SKYTROFA — Supplemental Application (Ascendis Pharma Endocrinology, Inc.)
The FDA approved a supplemental application for SKYTROFA (lonapegsomatropin-tcgD) from Ascendis Pharma Endocrinology, Inc., through a supple…
-
FDA approval · 2025-07-09FDA Approved: SOGROYA — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for SOGROYA (somapacitan-beco) from Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy
A completed study examining adipose tissue and circulating markers of inflammation in growth hormone deficiency and how these markers change…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Adipose Tissue and Serum Inflammation in GH Deficiency
This clinical trial update reports the completion of a study investigating adipose tissue and serum inflammation in individuals with growth …
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Body Composition and Adipose Tissue in HIV [Phase 4]
This clinical trial update reports completion of a Phase 4 study evaluating body composition and adipose tissue in individuals with HIV lipo…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children [Phase 2]
Phase 2 long-term follow-up study of MOD-4023, a long-acting growth hormone, in children with growth hormone deficiency has completed and po…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: A Bioavailability Study of Two Different PEG-rhGH Preparations. [Phase 1]
Phase 1 bioavailability study comparing two PEGylated recombinant human growth hormone (PEG-rhGH) preparations in pediatric growth hormone d…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations [Phase 1]
A Phase 1 trial comparing the pharmacokinetics of two PEGylated recombinant human growth hormone injections with different preparations in p…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations [Phase 1]
A Phase 1 study comparing the pharmacokinetics of two PEGylated recombinant human growth hormone preparations has completed in pediatric gro…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Development and Validation of a Self-assessment System Based on a Mobile App to Manage Adult Growth Hormone Deficiency [NA]
A completed clinical trial evaluating a mobile app-based self-assessment system to help manage adult Growth Hormone Deficiency, focusing on …